Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Brenzavvy™ (bexagliflozin) – New drug approval
January 23, 2023 - TheracosBio announced the FDA approval of Brenzavvy (bexagliflozin), as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
